TCI Wealth Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
TCI Wealth Advisors's HAE Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Haemonetics (HAE) in Q2 2023, closing a stake of 210 shares — an estimated $17.4K sold.
TCI Wealth Advisors first reported a position in HAE in Q2 2016 and held it in 28 quarters. The position peaked at $17.4K in Q1 2023. 294 funds tracked by Wall St. Rank hold HAE as of Q2 2023.
- TCI Wealth Advisors reported no remaining Haemonetics position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 210 Haemonetics shares in Q2 2023, an estimated $17.4K.
- TCI Wealth Advisors first reported a position in Haemonetics in Q2 2016 and held it in 28 quarters.
- TCI Wealth Advisors's Haemonetics position peaked at $17.4K in Q1 2023.
- 294 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.